Piper Sandler raises Jazz Pharmaceuticals' target price to $330 from $310
JAZZ•Piper Sandler raised its target price for Jazz Pharmaceuticals to $330 from $310.
Related News
Team Q3 2026 swings to operating loss of $471,000
TISI•
Top stories for November 12
XOM•
JetBlue debuts new domestic first class, key driver for targeted return to profit in 2027
JBLU•
Alphabet's debut Hong Kong, Singapore bond sales draw about $5 billion in early orders
GOOGL•
MSCI adds four Indian stocks to key global index in November review
MSCI•